Construction of the Eukaryotic Expression Vector of HCV NS3-5B and Its Expression in BHK-21 Cells
Han Pei-ju
Abstract
Han Pei-ju
Abstract
To construct the recombinant plasmid pIRES2-EGFP-NS3-5B,HCV NS3-5b gene was amplified by the polymerase chain reaction( PCR) and cloned into the eukaryotic expression plasmid pIRES2-EGFP. Then the recombinant plasmid was transfected into BHK-21 cells by Lipofectamine 2000 and the expression of target genes were identified by fluorescence imaging and western blot analysis. The results showed that the plasmid pIRES2-EGFP-NS3-5b was successfully constructed and NS3 /4A and NS5B proteins were specifically expressed in the eukaryotic cells. It provides the basis for the establishment of a cell-based HCV RdRp evaluation system and animal models development.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
To construct the recombinant plasmid pIRES2-EGFP-NS3-5B,HCV NS3-5b gene was amplified by the polymerase chain reaction( PCR) and cloned into the eukaryotic expression plasmid pIRES2-EGFP. Then the recombinant plasmid was transfected into BHK-21 cells by Lipofectamine 2000 and the expression of target genes were identified by fluorescence imaging and western blot analysis. The results showed that the plasmid pIRES2-EGFP-NS3-5b was successfully constructed and NS3 /4A and NS5B proteins were specifically expressed in the eukaryotic cells. It provides the basis for the establishment of a cell-based HCV RdRp evaluation system and animal models development.
Key concepts: Lipofectamine, Recombinant DNA, Plasmid, Molecular biology, Transfection, NS3, Virology, Vector (molecular biology)